Literature DB >> 23732239

Screening patterns within organized programs and survival of Italian women with invasive cervical cancer.

Antonella Zucchetto1, Guglielmo Ronco, Paolo Giorgi Rossi, Marco Zappa, Stefano Ferretti, Antonella Franzo, Fabio Falcini, Carmen Beatriz Visioli, Roberto Zanetti, Patrizia Biavati, Francesco La Rosa, Susanna Baracco, Massimo Federico, Cinzia Campari, Aldo De Togni, Silvano Piffer, Fabio Pannozzo, Mario Fusco, Maria Michiara, Marine Castaing, Pietro Seghini, Francesco Tisano, Diego Serraino.   

Abstract

OBJECTIVES: To evaluate screening patterns within organized cervical screening programs (OCSPs) and survival of women with invasive cervical cancer (ICC).
METHODS: A population-based study was conducted in Italian areas covered by cancer registries and OCSPs. The study included all women aged 25-65 years diagnosed with ICC between 1995 and 2008, and their screening histories within OCSPs were retrieved. Hazard ratios (HR) of death and 95% confidence intervals (CI) were computed according to screening pattern, using Cox models adjusted for age, ICC stage, and major confounders.
RESULTS: Among 3268 women with ICC, 20% were never-invited to OCSP, 36% were never-compliant with OCSP's invitation, 33% were compliant and had a screen-detected ICC within OCSP (i.e., after a positive cytology), and 11% were compliant but had a non-screen-detected ICC. Screen-detected ICCs were more frequently micro-invasive (42%) compared to non-screen-detected ones (14%). Compared to women with screen-detected ICC, the adjusted HRs of death were 1.9 (95% CI 1.5-2.4) for those never-invited, 2.0 (95% CI 1.6-2.5) for never-compliant, and 1.7 (95% CI 1.3-2.4) for compliant women having non-screen-detected ICC.
CONCLUSION: Prolonged survival, beyond down-staging, of women with ICC detected within OCSPs in Italy, further calls for improvements of OCSPs' invitational coverage and participation.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CI; CR; Cancer Registry; Cervical cancer; Cytology; FIGO; HR; ICC; ICD; International Classification of Diseases; International Federation of Gynecology and Obstetrics; NOS; OCSP; OR; Organized screening program; Screening history; WHO; World Health Organization; confidence interval; hazard ratio; invasive cervical cancer; not otherwise specified; odds ratio; organized cervical screening program

Mesh:

Year:  2013        PMID: 23732239     DOI: 10.1016/j.ypmed.2013.05.018

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  8 in total

1.  Underscreened Women Remain Overrepresented in the Pool of Cervical Cancer Cases in Spain: A Need to Rethink the Screening Interventions.

Authors:  Raquel Ibáñez; María Alejo; Neus Combalia; Xavier Tarroch; Josefina Autonell; Laia Codina; Montserrat Culubret; Francesc Xavier Bosch; Silvia de Sanjosé
Journal:  Biomed Res Int       Date:  2015-06-09       Impact factor: 3.411

2.  Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter.

Authors:  P Giorgi Rossi; C Fortunato; P Barbarino; S Boveri; S Caroli; A Del Mistro; A Ferro; C Giammaria; M Manfredi; T Moretto; A Pasquini; M Sideri; M C Tufi; C Cogo; E Altobelli
Journal:  Br J Cancer       Date:  2015-01-29       Impact factor: 7.640

3.  Efficacy of self-sampling in promoting participation to cervical cancer screening also in subsequent round.

Authors:  Annarosa Del Mistro; Helena Frayle; Antonio Ferro; Gianpiero Fantin; Emma Altobelli; Paolo Giorgi Rossi
Journal:  Prev Med Rep       Date:  2016-12-23

4.  Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia.

Authors:  Michaela T Hall; Kate T Simms; Jie-Bin Lew; Megan A Smith; Marion Saville; Karen Canfell
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

Review 5.  Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination-Review of Current Perspectives.

Authors:  Chee Kai Chan; Gulzhanat Aimagambetova; Talshyn Ukybassova; Kuralay Kongrtay; Azliyati Azizan
Journal:  J Oncol       Date:  2019-10-10       Impact factor: 4.375

6.  Incidence Trends of Cervical Cancer and Its Precancerous Lesions in Women of Central Switzerland from 2000 until 2014.

Authors:  Katrin Ochs; Gesine Meili; Joachim Diebold; Volker Arndt; Andreas Günthert
Journal:  Front Med (Lausanne)       Date:  2018-03-16

7.  Human papilloma virus genotyping for the cross-sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more.

Authors:  Annarosa Del Mistro; Rachael Adcock; Francesca Carozzi; Anna Gillio-Tos; Laura De Marco; Salvatore Girlando; Raffaella Rizzolo; Helena Frayle; Morena Trevisan; Cristina Sani; Elena Burroni; Paolo Giorgi Rossi; Jack Cuzick; Guglielmo Ronco
Journal:  Int J Cancer       Date:  2018-03-09       Impact factor: 7.396

8.  Cervical cancer screening history prior to a diagnosis of cervical cancer in Danish women aged 60 years and older-A national cohort study.

Authors:  Anne Hammer; Vibeke Soegaard; Rikke D Maimburg; Jan Blaakaer
Journal:  Cancer Med       Date:  2019-01-01       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.